163 related articles for article (PubMed ID: 18230366)
21. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
22. LPS-binding protein and CD14-dependent attachment of hepatitis B surface antigen to monocytes is determined by the phospholipid moiety of the particles.
Vanlandschoot P; Van Houtte F; Roobrouck A; Farhoudi A; Stelter F; Peterson DL; Gomez-Gutierrez J; Gavilanes F; Leroux-Roels G
J Gen Virol; 2002 Sep; 83(Pt 9):2279-2289. PubMed ID: 12185283
[TBL] [Abstract][Full Text] [Related]
23. The fifth domain of beta 2-glycoprotein I contains a phospholipid binding site (Cys281-Cys288) and a region recognized by anticardiolipin antibodies.
Hunt J; Krilis S
J Immunol; 1994 Jan; 152(2):653-9. PubMed ID: 7506730
[TBL] [Abstract][Full Text] [Related]
24. Heparin inhibits the binding of beta 2-glycoprotein I to phospholipids and promotes the plasmin-mediated inactivation of this blood protein. Elucidation of the consequences of the two biological events in patients with the anti-phospholipid syndrome.
Guerin J; Sheng Y; Reddel S; Iverson GM; Chapman MG; Krilis SA
J Biol Chem; 2002 Jan; 277(4):2644-9. PubMed ID: 11711550
[TBL] [Abstract][Full Text] [Related]
25. An A1-A1 mutant with improved binding and inhibition of β2GPI/antibody complexes in antiphospholipid syndrome.
Kolyada A; Karageorgos I; Mahlawat P; Beglova N
FEBS J; 2015 Mar; 282(5):864-73. PubMed ID: 25546421
[TBL] [Abstract][Full Text] [Related]
26. Role of divalency in the high-affinity binding of anticardiolipin antibody-beta 2-glycoprotein I complexes to lipid membranes.
Willems GM; Janssen MP; Pelsers MM; Comfurius P; Galli M; Zwaal RF; Bevers EM
Biochemistry; 1996 Oct; 35(43):13833-42. PubMed ID: 8901526
[TBL] [Abstract][Full Text] [Related]
27. Phospholipid-bound beta 2-glycoprotein I induces the production of anti-phospholipid antibodies.
Subang R; Levine JS; Janoff AS; Davidson SM; Taraschi TF; Koike T; Minchey SR; Whiteside M; Tannenbaum M; Rauch J
J Autoimmun; 2000 Aug; 15(1):21-32. PubMed ID: 10936025
[TBL] [Abstract][Full Text] [Related]
28. [Antiphospholipid and anti beta 2-glycoprotein I antibodies].
Arvieux J; Roussel B; Colomb MG
Ann Biol Clin (Paris); 1994; 52(5):381-5. PubMed ID: 7856939
[TBL] [Abstract][Full Text] [Related]
29. Standardization of immunoassays for antiphospholipid antibodies with beta 2GPI and role of other phospholipid cofactors.
Amiral J; Larrivaz I; Cluzeau D; Adam M
Haemostasis; 1994; 24(3):191-203. PubMed ID: 7527366
[TBL] [Abstract][Full Text] [Related]
30. Structure and function of the recombinant fifth domain of human beta 2-glycoprotein I: effects of specific cleavage between Lys77 and Thr78.
Hagihara Y; Enjyoji K; Omasa T; Katakura Y; Suga K; Igarashi M; Matsuura E; Kato H; Yoshimura T; Goto Y
J Biochem; 1997 Jan; 121(1):128-37. PubMed ID: 9058203
[TBL] [Abstract][Full Text] [Related]
31. Human beta2-glycoprotein I as an anticardiolipin cofactor determined using mutants expressed by a baculovirus system.
Igarashi M; Matsuura E; Igarashi Y; Nagae H; Ichikawa K; Triplett DA; Koike T
Blood; 1996 Apr; 87(8):3262-70. PubMed ID: 8605342
[TBL] [Abstract][Full Text] [Related]
32. Identification of structural mutations in the fifth domain of apolipoprotein H (beta 2-glycoprotein I) which affect phospholipid binding.
Sanghera DK; Wagenknecht DR; McIntyre JA; Kamboh MI
Hum Mol Genet; 1997 Feb; 6(2):311-6. PubMed ID: 9063752
[TBL] [Abstract][Full Text] [Related]
33. Anionic phospholipids bind to L-selectin (but not E-selectin) at a site distinct from the carbohydrate-binding site.
Malhotra R; Taylor NR; Bird MI
Biochem J; 1996 Feb; 314 ( Pt 1)(Pt 1):297-303. PubMed ID: 8660298
[TBL] [Abstract][Full Text] [Related]
34. Plasmin can reduce the function of human beta2 glycoprotein I by cleaving domain V into a nicked form.
Ohkura N; Hagihara Y; Yoshimura T; Goto Y; Kato H
Blood; 1998 Jun; 91(11):4173-9. PubMed ID: 9596664
[TBL] [Abstract][Full Text] [Related]
35. Primary antiphospholipid antibody syndrome with mutations in the phospholipid binding domain of beta(2)-glycoprotein I.
Gushiken FC; Arnett FC; Thiagarajan P
Am J Hematol; 2000 Oct; 65(2):160-5. PubMed ID: 10996835
[TBL] [Abstract][Full Text] [Related]
36. Polymorphisms beta2-glycoprotein I: phospholipid binding and multimeric structure.
Gushiken FC; Le A; Arnett FC; Thiagarajan P
Thromb Res; 2002 Nov; 108(2-3):175-80. PubMed ID: 12590955
[TBL] [Abstract][Full Text] [Related]
37. Anti-phospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a beta 2-glycoprotein I-dependent manner.
Price BE; Rauch J; Shia MA; Walsh MT; Lieberthal W; Gilligan HM; O'Laughlin T; Koh JS; Levine JS
J Immunol; 1996 Sep; 157(5):2201-8. PubMed ID: 8757347
[TBL] [Abstract][Full Text] [Related]
38. Phospholipid-independent binding of beta 2glycoprotein I by IgA from patients with antiphospholipid syndrome.
Galazka MW; Keil LB; Kohles J; Petersheim M; DeBari VA
Ann Clin Lab Sci; 1998; 28(3):153-9. PubMed ID: 9646856
[TBL] [Abstract][Full Text] [Related]
39. Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I.
Roubey RA; Pratt CW; Buyon JP; Winfield JB
J Clin Invest; 1992 Sep; 90(3):1100-4. PubMed ID: 1522218
[TBL] [Abstract][Full Text] [Related]
40. Microheterogeneity of beta-2 glycoprotein I: implications for binding to anionic phospholipids.
Brighton TA; Dai YP; Hogg PJ; Chesterman CN
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):59-67. PubMed ID: 10229659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
